07:00 , Oct 16, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Approach Summary Licensing status Publication and contact information Markers Gelsolin (GSN) as a marker for cisplatin sensitivity and patient survival in ovarian cancer Studies in patient samples and cell culture suggest GSN could be a...
07:00 , Oct 15, 2012 |  BC Week In Review  |  Clinical News

ONC107 diagnostic data

Onconome Inc. , Seattle, Wash.   Product: ONC107 (CRC Assay)   Business: Diagnostic   Molecular target: NA   Description: Assay using mass spectrometry to measure single peptides from 7 serum proteins   Indication: Predict risk...
07:00 , May 30, 2011 |  BC Week In Review  |  Company News

BioAegis Therapeutics, Brigham and Women's Hospital deal

The hospital granted BioAegis an exclusive option to license worldwide rights to endogenous human protein plasma gelsolin (pGSN) for therapeutic and diagnostic uses. The option is exercisable at the close of BioAegis' series A financing....
07:00 , Sep 11, 2008 |  BC Innovations  |  Targets & Mechanisms

Evasin Invasion

Researchers at Merck KGaA have found that ticks, parasites better known as transmission vectors for diseases such as Lyme disease, may be a source of therapeutically useful molecules. They have identified several selective chemokine-binding proteins...
07:00 , May 19, 2008 |  BC Week In Review  |  Clinical News

Solinex: Phase IIa started

Critical Biologics began a double-blind, placebo-controlled, Chinese Phase IIa trial of intravenous Solinex in 40 patients. Critical Biologics Corp. , Cambridge, Mass.   Product: Solinex   Business: Hematology   Molecular target: Not available   Description:...
07:00 , Oct 13, 1997 |  BC Week In Review  |  Company News

Chiron other research news

CHIR and collaborators published the role of a protein called gelsolin in apoptosis, showing in a report in Science that gelsolin is cut apart during cell suicide. The fragment left behind can break down the...
07:00 , Oct 13, 1997 |  BC Week In Review  |  Company News

Chiron other research news

CHIR and collaborators published the role of a protein called gelsolin in apoptosis, showing in a report in Science that gelsolin is cut apart during cell suicide. The fragment left behind can break down the...
07:00 , Oct 21, 1996 |  BC Week In Review  |  Clinical News

Gelsolin recombinant actin-severing protein: Phase I trial in the U.K.

Biogen Inc. (BGEN), Cambridge, Mass.   Product: Gelsolin recombinant actin-severing protein   Indication: Respiratory diseases   Status: BGEN began a Phase I trial in the U.K. in healthy volunteers. Gelsolin is an actin-severing protein derived...
08:00 , Feb 28, 1994 |  BC Week In Review  |  Company News

Biogen other research news

Gelsolin, a protein from human plasma that severs actin fibers, can thin the mucus of cystic fibrosis (CF) patients. Harvard researchers showed that the mucus contains filamentous actin, and that gelsolin decreased the viscosity of...